Multi-omics Analysis of Immune Determinants of STK11 in Non-Small Cell Lung Cancer

被引：0
|
作者：
Alhushki, S. K. [1 ]
Al-Muhtaseb, A. [2 ]
Abushukair, H. [3 ]
Abulrous, F. [4 ]
机构：
[1] Mutah Univ, Al Karak, Jordan
[2] Hashemite Univ, Zarqa, Jordan
[3] Jordan Univ Sci & Technol, Irbid, Jordan
[4] Henry Ford Hlth, Detroit, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
STK11; Immunotherapy; Non-small Cell Lung Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP03.03-02
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [41] Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets
    Luan, Mingyuan
    Song, Fucheng
    Qu, Shuyuan
    Meng, Xi
    Ji, Junjie
    Duan, Yunbo
    Sun, Changgang
    Si, Hongzong
    Zhai, Honglin
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [42] Emerging insights into STK11, KEAP1 and KRAS mutations: implications for immunotherapy in patients with advanced non-small cell lung cancer
    Knetki-Wroblewska, Magdalena
    Wojas-Krawczyk, Kamila
    Krawczyk, Pawel
    Krzakowski, Maciej
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (12) : 3718 - 3730
  • [43] STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
    Di Federico, Alessandro
    De Giglio, Andrea
    Parisi, Claudia
    Gelsomino, Francesco
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 108 - 113
  • [44] Impact of STK11 copy loss on clinical outcomes to PD-(L)1 blockade in non-small cell lung cancer.
    Gutierrez, Catherine
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Pecci, Federica
    De Castro Barrichello, Adriana Paula
    Vaz, Victor R.
    Sholl, Lynette M.
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
    Wang, Chengdi
    Li, Jingwei
    Chen, Jingyao
    Wang, Zhoufeng
    Zhu, Guonian
    Song, Lujia
    Wu, Jiayang
    Li, Changshu
    Qiu, Rong
    Chen, Xuelan
    Zhang, Li
    Li, Weimin
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [46] To Construct Multi-Omics Modelfor Predicting Prognosis of Definitive Chemoradiotherapyin Locally Advanced Non-Small Cell Lung Cancer
    Li, L.
    Song, X.
    Liu, N.
    Zhou, T.
    Yuan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S567 - S567
  • [47] The Efficacy of Immunotherapy and Chemoimmunotherapy in STK11, KEAP1 & KRAS Gene Mutations in Advanced Non-small Cell Lung Cancer (NSCLC)
    Cheung, T. W.
    Morales, J.
    Sacks, H.
    Rolfo, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S630 - S630
  • [48] Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
    Bourbonne, Vincent
    Geier, Margaux
    Schick, Ulrike
    Lucia, Francois
    BIOMEDICINES, 2022, 10 (06)
  • [49] Molecular Spectrum of STK11 Gene Mutations in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
    Chen, X.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Chen, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2099 - S2100
  • [50] Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy
    Mazzaschi, Giulia
    Leonetti, Alessandro
    Minari, Roberta
    Gnetti, Letizia
    Quaini, Federico
    Tiseo, Marcello
    Facchinetti, Francesco
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (11)
12345